VBIV
VBI Vaccines, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website vbivaccines.com
- Employees(FY) 190
- ISIN CA91822J2020
Performance
+4.43%
1W
+1.61%
1M
-2.51%
3M
+6.24%
6M
+7.23%
YTD
-78.72%
1Y
Profile
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, an immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; GlaxoSmithKline Biologicals S.A.; and the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. It also has a collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
Technical Analysis of VBIV 2024-05-10
Overview:
In analyzing the technical indicators for VBIV over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...
Recent News & Updates
- 2024-05-15 09:54
- 2024-05-15 04:00
- 2024-04-16 01:52
- 2024-04-15 20:00
VBI Vaccines Reports Full Year 2023 Financial Results(Businesswire)
- 2024-04-11 04:05
- 2024-04-09 02:45
- 2024-04-02 20:00
- 2024-04-01 20:00
- 2024-03-21 19:00
- 2024-02-13 23:48
- 2024-02-13 18:00
- 2024-02-13 06:04
- 2023-11-19 19:00
- 2023-11-14 03:05
- 2023-10-25 20:00
- 2023-09-26 19:30
- 2023-09-06 20:00
- 2023-09-05 20:00
- 2023-08-13 20:00
VBI Vaccines Reports Second Quarter 2023 Financial Results(Yahoo Finance)
- 2023-08-03 06:25
- 2023-07-23 20:00
- 2023-07-18 20:00
- 2023-07-12 19:00
7 Biotech Stocks to Sell in July(Yahoo Finance)
- 2023-07-05 21:00
- 2023-07-05 04:12
- 2023-07-05 04:01
- 2023-06-23 04:05
VBI Vaccines Announces Results of Annual General Meeting(Yahoo Finance)
- 2023-06-14 20:00
- 2023-06-06 20:00
VBI Vaccines Announces Poster Presentation at EASL 2023(Yahoo Finance)
- 2023-06-03 21:32
Page 1 of 4
previousnext